What is he best known for?
The fields of study he is best known for:
R. Suzanne Zukin focuses on Neuroscience, Synaptic plasticity, Internal medicine, Endocrinology and AMPA receptor. His biological study spans a wide range of topics, including Anxiety, Psychiatry, Mood disorders and Schizophrenia. In the field of Synaptic plasticity, his study on Metaplasticity overlaps with subjects such as Gene silencing, Rett syndrome and Chromatin remodeling.
In Internal medicine, R. Suzanne Zukin works on issues like Pharmacology, which are connected to Receptor. His study on Silent synapse is often connected to Downregulation and upregulation as part of broader study in AMPA receptor. His study in Ischemia is interdisciplinary in nature, drawing from both Hippocampal formation and Neuron.
His most cited work include:
- Electrical Coupling and Neuronal Synchronization in the Mammalian Brain (639 citations)
- Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders (417 citations)
- Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death (392 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Neuroscience, Cell biology, Internal medicine, Endocrinology and Receptor. His Neuroscience study integrates concerns from other disciplines, such as Synaptic plasticity, Long-term depression, Fragile X syndrome and Metabotropic glutamate receptor. His studies deal with areas such as NMDA receptor, AMPA receptor, Glutamate receptor, Long-term potentiation and Ischemic preconditioning as well as Cell biology.
His biological study deals with issues like Pharmacology, which deal with fields such as Narcotic antagonist and Dihydromorphine. His work deals with themes such as Agonist, Opioid receptor and Binding site, which intersect with Endocrinology. His study explores the link between Ischemia and topics such as Hippocampal formation that cross with problems in Hippocampus.
He most often published in these fields:
- Neuroscience (33.59%)
- Cell biology (27.34%)
- Internal medicine (26.56%)
What were the highlights of his more recent work (between 2010-2021)?
- Neuroscience (33.59%)
- Ischemia (19.53%)
- Hippocampal formation (14.06%)
In recent papers he was focusing on the following fields of study:
Neuroscience, Ischemia, Hippocampal formation, Cell biology and Neuroprotection are his primary areas of study. His Neuroscience research is multidisciplinary, relying on both Synaptic plasticity, Mitochondrion, NMDA receptor and Fragile X syndrome. His NMDA receptor research integrates issues from Long-term potentiation, Pharmacology and Phosphorylation.
Internal medicine covers R. Suzanne Zukin research in Ischemia. His work is dedicated to discovering how Hippocampal formation, Ischemic preconditioning are connected with Glutamate receptor and other disciplines. His work in Cell biology is not limited to one particular discipline; it also encompasses hERG.
Between 2010 and 2021, his most popular works were:
- Serotonin Mediates Cross-Modal Reorganization of Cortical Circuits (106 citations)
- EphB controls NMDA receptor function and synaptic targeting in a subunit-specific manner (100 citations)
- Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment (86 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
